3.63
price up icon0.28%   0.010
after-market After Hours: 3.65 0.02 +0.55%
loading

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Forecast

The Scinai Immunotherapeutics Ltd Adr (SCNI) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.1889, representing a -94.80% decrease from the current price of $3.63. The highest analyst price target is $0.2397, and the lowest is $0.1381.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SCNI Price Target
Average 0.1748 (-95.18% Downside)
loading

Is Scinai Immunotherapeutics Ltd Adr (SCNI) A Buy Now?

Oscillators
Name Value Action
RSI(14) 48.44 Neutral
STOCH(9,6) 51.18 Neutral
STOCHRSI(14) 31.23 Neutral
MACD(12,26) -0.00318 Buy
ADX(14) 34.06 Buy
William %R -50.77 Neutral
CCI(14) 28.62 Neutral
Buy: 2 Sell: 0 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
3.7015
Sell
3.6854
Sell
MA20
3.6623
Sell
3.6832
Sell
MA50
3.725
Sell
3.7295
Sell
MA100
3.727
Sell
3.9213
Sell
MA200
4.3124
Sell
4.6798
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, SCNI could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on SCNI, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 48.44 indicates that SCNI is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 51.18 indicates that SCNI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 31.23 indicates that SCNI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 34.06 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 28.62 indicates that SCNI is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term SCNI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Scinai Immunotherapeutics Ltd Adr financial reports and earnings history, Scinai Immunotherapeutics Ltd Adr (SCNI) stock could reach $2.4284 by 2030, $10.70 by 2040 and $14.69 by 2050. See the projected annual prices until 2050 of the Scinai Immunotherapeutics Ltd Adr stock below:

  • Scinai Immunotherapeutics Ltd Adr (SCNI) is expected to reach an average price of $5.8014 in 2035, with a high prediction of $6.30 and a low estimate of $5.8014. This indicates an $59.82% rise from the last recorded price of $3.63.
  • Scinai Immunotherapeutics Ltd Adr (SCNI) stock is projected to chart a bullish course in 2040, with an average price target of $10.81, representing an $197.68% surge from its current level. The forecast ranges from a conservative $4.8114 to a sky-high $10.70.
  • Our analysts predict Scinai Immunotherapeutics Ltd Adr (SCNI) to jump 137.52% by 2045, soaring from $8.6499 to an average price of $8.6218, potentially reaching $9.2127. While $8.6499 is the low estimate, the potential upside is significant.
  • Scinai Immunotherapeutics Ltd Adr (SCNI) stock is expected to climb by 2050, reaching an average of $13.95, a $284.35% jump from its current level. However, a wide range of estimates exists, with high and low targets of $14.69 and $14.02, respectively, highlighting the market's uncertainty.

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Year by Year Forecast

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2024

Our forecast for SCNI stock price in 2024 now indicates an average price target of $0.4371 with a high forecast of $0.8296 and a low forecast of $0.0446. The average prediction reflects an decrease of -87.96% from the last recorded price of $3.63.
Month Average Low High Change from today's price
November, 2024 $0.2053 $0.1381 $0.2397 -94.34%
December, 2024 $0.1817 $0.162 $0.234 -94.99%

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2025

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) is expected to reach an average price of $0.4106 in 2025, with a high prediction of $0.7607 and a low estimate of $0.0605. This indicates an -88.69% fall from the last recorded price of $3.63.
Month Average Low High Change from today's price
January, 2025 $0.1988 $0.1581 $0.2394 -94.52%
February, 2025 $0.2701 $0.1308 $0.2892 -92.56%
March, 2025 $0.3138 $0.3444 $0.2738 -91.35%
April, 2025 $0.1784 $0.3142 $0.2681 -95.08%
May, 2025 $0.1532 $0.1669 $0.1321 -95.78%
June, 2025 $0.2252 $0.2257 $0.1952 -93.80%
July, 2025 $0.2185 $0.2388 $0.1946 -93.98%
August, 2025 $0.1135 $0.162 $0.1535 -96.87%
September, 2025 $0.1065 $0.1116 $0.0824 -97.07%
October, 2025 $0.0582 $0.0605 $0.0559 -98.40%
November, 2025 $0.7875 $0.6712 $0.6279 -78.30%
December, 2025 $0.7678 $0.8178 $0.7607 -78.85%

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2026

The predicted value for Scinai Immunotherapeutics Ltd Adr (SCNI) in 2026 is set at an average of $0.7791. Estimates vary from a peak of $1.2477 to a trough of $0.3105, indicating an -78.54% surge from the present price of $3.63.
Month Average Low High Change from today's price
January, 2026 $0.6271 $0.7629 $0.7321 -82.72%
February, 2026 $0.5713 $0.6003 $0.5732 -84.26%
March, 2026 $0.6128 $0.6286 $0.5828 -83.12%
April, 2026 $0.5678 $0.5881 $0.5718 -84.36%
May, 2026 $0.4323 $0.4836 $0.4952 -88.09%
June, 2026 $0.3948 $0.4075 $0.3935 -89.13%
July, 2026 $0.3197 $0.3105 $0.3289 -91.19%
August, 2026 $1.305 $1.2116 $1.1454 -64.05%
September, 2026 $1.2471 $1.2971 $1.2477 -65.64%
October, 2026 $1.0758 $1.2116 $1.1961 -70.36%
November, 2026 $0.9895 $1.0337 $1.0143 -72.74%
December, 2026 $0.9998 $1.03 $0.9709 -72.46%

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Scinai Immunotherapeutics Ltd Adr (SCNI) is $1.1476, with a high forecast of $1.7346 and a low forecast of $0.5606. This indicates an -68.39% decrease from the last price of $3.63.
Month Average Low High Change from today's price
January, 2027 $0.9172 $0.9375 $0.9392 -74.73%
February, 2027 $0.7512 $0.8025 $0.837 -79.31%
March, 2027 $0.6424 $0.6724 $0.7047 -82.30%
April, 2027 $0.5812 $0.5606 $0.6019 -83.99%
May, 2027 $1.8225 $1.752 $1.6656 -49.79%
June, 2027 $1.7264 $1.7764 $1.7346 -52.44%
July, 2027 $1.5246 $1.6604 $1.6601 -58.00%
August, 2027 $1.4076 $1.4671 $1.4553 -61.22%
September, 2027 $1.3797 $1.4122 $1.3661 -61.99%
October, 2027 $1.2666 $1.2869 $1.3115 -65.11%
November, 2027 $1.07 $1.1213 $1.1787 -70.52%
December, 2027 $0.9231 $0.9531 $1.0159 -74.57%

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2028

In 2028, Scinai Immunotherapeutics Ltd Adr (SCNI) is projected to reach an average price of $1.7698, with a high projection of $2.7289 and a low estimate of $0.8106. This indicates an -51.25% fall from the last price of $3.63.
Month Average Low High Change from today's price
January, 2028 $0.8428 $0.8106 $0.8749 -76.78%
February, 2028 $2.34 $2.2866 $2.1907 -35.54%
March, 2028 $2.2056 $2.2556 $2.2215 -39.24%
April, 2028 $1.9733 $2.1091 $2.1241 -45.64%
May, 2028 $1.8676 $1.8979 $1.8964 -48.55%
June, 2028 $1.7597 $1.7922 $1.7672 -51.52%
July, 2028 $1.616 $1.6363 $1.6838 -55.48%
August, 2028 $1.3696 $1.3871 $1.5204 -62.27%
September, 2028 $1.2037 $1.2337 $1.2962 -66.84%
October, 2028 $1.1043 $1.0607 $1.1478 -69.58%
November, 2028 $2.809 $2.8193 $2.7289 -22.62%
December, 2028 $2.6849 $2.7349 $2.7084 -26.04%

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2029

The 2029 price forecast for Scinai Immunotherapeutics Ltd Adr Stock (SCNI) is $2.2758 on average, with a high prediction of $3.2409 and a low estimate of $1.3107. This represents an -37.30% decrease from the previous price of $3.63.
Month Average Low High Change from today's price
January, 2029 $2.3849 $2.3849 $2.5914 -34.30%
February, 2029 $2.2781 $2.316 $2.284 -37.24%
March, 2029 $2.1396 $2.1721 $2.1701 -41.06%
April, 2029 $1.9654 $1.9857 $2.0561 -45.86%
May, 2029 $1.6807 $1.6982 $1.8622 -53.70%
June, 2029 $1.4843 $1.5143 $1.5997 -59.11%
July, 2029 $1.3658 $1.3107 $1.4208 -62.38%
August, 2029 $3.3188 $3.3521 $3.2409 -8.57%
September, 2029 $3.1642 $3.2142 $3.1953 -12.83%
October, 2029 $2.826 $2.826 $3.0631 -22.15%
November, 2029 $2.6886 $2.7331 $2.7174 -25.93%
December, 2029 $2.5195 $2.552 $2.5729 -30.59%

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Price Forecast for 2030

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) is expected to reach an average price of $2.6653 in 2030, with a high forecast of $3.7698 and a low forecast of $1.5608. This signifies an -26.58% decrease from the last price of $3.63.
Month Average Low High Change from today's price
January, 2030 $2.2439 $2.2531 $2.4284 -38.18%
February, 2030 $1.9919 $2.0094 $2.1528 -45.13%
March, 2030 $1.7649 $1.7949 $1.9033 -51.38%
April, 2030 $1.6273 $1.5608 $1.6938 -55.17%
May, 2030 $3.8286 $3.8848 $3.7698 +5.47%
June, 2030 $3.6435 $3.6935 $3.6822 +0.37%
July, 2030 $3.267 $3.267 $3.5347 -10.00%
August, 2030 $3.0992 $3.1437 $3.1509 -14.62%
September, 2030 $2.8995 $2.932 $2.9758 -20.12%
October, 2030 $2.5856 $2.5948 $2.8007 -28.77%
November, 2030 $2.3031 $2.3206 $2.4869 -36.55%
December, 2030 $2.0455 $2.0755 $2.2068 -43.65%
$21.57
price down icon 8.06%
$372.81
price up icon 0.77%
$54.82
price down icon 4.59%
$212.39
price down icon 4.40%
$114.47
price down icon 2.78%
$543.84
price up icon 0.60%
Cap:     |  Volume (24h):